{
    "1663462805243146240": {
        "attachments": {
            "media_keys": [
                "13_1663462757935587329"
            ]
        },
        "author_id": "62465691",
        "created_at": "2023-05-30T08:30:13.000Z",
        "edit_history_tweet_ids": [
            "1663462805243146240"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 50,
                    "normalized_text": "endometrial cancer",
                    "probability": 0.5644,
                    "start": 33,
                    "type": "Other"
                }
            ],
            "urls": [
                {
                    "display_url": "pic.twitter.com/4b3UtOC4Sr",
                    "end": 286,
                    "expanded_url": "https://twitter.com/AstraZeneca/status/1663462805243146240/video/1",
                    "media_key": "13_1663462757935587329",
                    "start": 263,
                    "url": "https://t.co/4b3UtOC4Sr"
                }
            ]
        },
        "id": "1663462805243146240",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 5048,
            "like_count": 14,
            "quote_count": 0,
            "reply_count": 4,
            "retweet_count": 2
        },
        "text": "Patients diagnosed with advanced endometrial cancer have limited care options and poor prognoses compared to those diagnosed at an earlier stage.\n\nIt is crucial that new research delivers expanded and improved care options, ultimately enhancing patient outcomes. https://t.co/4b3UtOC4Sr"
    }
}